Literature DB >> 15133727

End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome.

Lavjay Butani1.   

Abstract

Primary anti-phospholipid syndrome (APS) is perceived to be an uncommon disorder, infrequently recognized as a cause of renal disease in childhood. While renal involvement in APS classically manifests as thrombotic events, other renal diseases associated with APS have been reported in adults, including membranous nephropathy and minimal change disease. We report our experience of caring for a child who presented with acute anuric renal failure due to anti-neutrophilic cytoplasmic antibody-negative rapidly progressive glomerulonephritis (RPGN), with concomitant thrombotic microangiopathy (TMA). Recognition of the APS as a cause of the patient's TMA facilitated institution of anticoagulation. Our patient's renal failure did not improve and the patient remained dependent on dialysis until he was successfully transplanted. The purpose of our report is to make health-care professionals aware of the previously unreported association of pauci-immune RPGN and APS in children; early recognition of APS will allow initiation of anticoagulation to prevent recurrent thromboses and enable successful transplantation.

Entities:  

Mesh:

Year:  2004        PMID: 15133727     DOI: 10.1007/s00467-004-1491-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 2.  Pulmonary embolism.

Authors:  S Z Goldhaber
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245

Review 3.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

4.  The intrarenal vascular lesions associated with primary antiphospholipid syndrome.

Authors:  D Nochy; E Daugas; D Droz; H Beaufils; J P Grünfeld; J C Piette; J Bariety; G Hill
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

5.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

6.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

7.  Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  Emily von Scheven; David V Glidden; Melissa E Elder
Journal:  Arthritis Rheum       Date:  2002-08

Review 8.  The expanding spectrum of renal diseases associated with antiphospholipid syndrome.

Authors:  Fadi Fakhouri; Laure-Hélène Noël; Julien Zuber; Hélène Beaufils; Frank Martinez; Pierre Lebon; Thomas Papo; Dominique Chauveau; Olivier Bletry; Jean-Pierre Grünfeld; Jean-Charles Piette; Philippe Lesavre
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

Review 9.  Venous thromboembolic events in pediatric patients. Diagnosis and management.

Authors:  W Streif; M E Andrew
Journal:  Hematol Oncol Clin North Am       Date:  1998-12       Impact factor: 3.722

10.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245

View more
  7 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

2.  Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy.

Authors:  Swasti Chaturvedi; Leonardo Brandao; Denis Geary; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

3.  Thrombotic microangiopathy as a complication in a patient with focal segmental glomerulosclerosis.

Authors:  Kerstin Benz; Kerstin Amann; Katalin Dittrich; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2007-09-20       Impact factor: 3.714

Review 4.  Renal involvement in antiphospholipid syndrome.

Authors:  Savino Sciascia; Maria José Cuadrado; Munther Khamashta; Dario Roccatello
Journal:  Nat Rev Nephrol       Date:  2014-03-18       Impact factor: 28.314

5.  Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants.

Authors:  R K Sharma; A Kaul; V Agrawal; K Jaisuresh
Journal:  Indian J Nephrol       Date:  2011-10

Review 6.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

Review 7.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.